- Review
Background: Several studies have shown that inhibitors of proprotein convertase kexin 9 (PCSK9 ) efficiently lowered levels of low-density lipoprotein cholesterol (LDL-C), especially in patients with familial hypercholesterolaemia, intolerant of stat...

